On this page
What this guide covers
Semaglutide (Ozempic) is not recommended during pregnancy, and the label advises stopping it well before trying to conceive. Here is what the guidance actually says about conception, contraception, breastfeeding, and an unplanned pregnancy. This is patient education, not a substitute for the prescriber who knows your case. Generic names sit next to brand names throughout: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound).
Key points
- The short answer: not during pregnancy. The FDA prescribing information advises against using semaglutide (Ozempic) during pregnancy. The reasoning is twofold: animal reproduction studies showed harm to the developing fetus, and there is not enough human data to establish safety, so the guidance errs firmly on the side of caution. On top of that, pregnancy is a time to gain appropriate weight, not lose it, which is at odds with how these drugs work. The label's practical instruction follows from all this: discontinue semaglutide when a pregnancy is recognized, and, because the drug lingers, stop it a set time before planning to conceive. The specifics of that timing are below, but the headline is simple, this is not a medication to take while pregnant or actively trying.
- Stopping before you try to conceive. Semaglutide has a long half-life, meaning it clears the body slowly and stays in your system for weeks after the last injection. Because of that, the Ozempic label advises stopping the drug at least two months before a planned pregnancy, so it is largely cleared before conception. This is one of the clearest, most specific pieces of guidance on the label, and it is easy to overlook if you are not planning ahead. If parenthood is on your horizon, this is a conversation to have with your prescriber early, both to time the stop correctly and to plan how your diabetes or weight will be managed in the meantime, since coming off the drug changes that picture.
- Contraception and the birth-control question. Because the drug is not for use in pregnancy, reliable contraception matters if you could become pregnant and are not trying to. There is a specific wrinkle for people using the higher-dose weight-management formulations of this drug class: the tirzepatide (Mounjaro, Zepbound) label warns that its effect on stomach emptying may reduce the absorption of oral birth-control pills, and advises using a barrier method or switching to a non-oral contraceptive for a window after starting or increasing the dose. The semaglutide labeling handles this differently, but the underlying point holds, if you rely on the pill, this is worth raising with your prescriber so you are not caught out. Do not assume your contraception is unaffected; ask.
- If you find out you are already pregnant. First, do not panic, and do not make it a solo decision in the middle of the night. The guidance is to stop the medication and contact your prescriber promptly so they can advise you and adjust how your underlying condition is managed. An unplanned pregnancy on a GLP-1 drug is not rare, and your clinician has seen it; the useful move is a prompt call rather than guilt or guesswork. There is also a pregnancy exposure registry for semaglutide that collects outcome data, and your clinician can tell you how to take part if you wish, which helps build the human evidence that is currently thin. What matters most right now is getting the medication stopped and getting proper prenatal care underway.
- Breastfeeding and after the birth. The caution extends past delivery. The Ozempic label advises against use while breastfeeding, because it is not known whether semaglutide passes into human milk or what effect it might have on a nursing infant, and again the human data is limited. If weight or blood-sugar management is a concern during this period, that is a discussion to have with your clinician about options that are compatible with nursing, rather than restarting the drug on your own. When and whether to resume semaglutide after weaning is likewise a prescriber decision, weighing your health goals against the timing. The theme throughout pregnancy, contraception, and breastfeeding is the same: this is a plan to make with your clinician, not a set of choices to improvise.
Frequently asked questions
Can you take Ozempic while pregnant?
No. The FDA prescribing information advises against using semaglutide (Ozempic) during pregnancy. Animal studies showed harm to the developing fetus and human safety data is limited, so the guidance is to discontinue the drug when a pregnancy is recognized. Pregnancy is also a time to gain appropriate weight rather than lose it, which conflicts with how the medication works.
How long should I stop Ozempic before trying to get pregnant?
The Ozempic label advises stopping the drug at least two months before a planned pregnancy. Semaglutide has a long half-life and clears the body slowly, so this window allows it to be largely eliminated before conception. Because coming off the drug also changes how your diabetes or weight is managed, plan the stop with your prescriber well in advance rather than timing it yourself.
Does Ozempic affect birth control pills?
For semaglutide (Ozempic) the labeling handles this differently from its sister drugs, but the caution is worth knowing: the tirzepatide (Mounjaro, Zepbound) label warns that delayed stomach emptying may reduce absorption of oral contraceptives and advises a barrier method or a non-oral option for a window after starting or increasing the dose. If you rely on the pill, do not assume you are unaffected, ask your prescriber.
What should I do if I get pregnant while taking Ozempic?
Stop the medication and contact your prescriber promptly so they can advise you and adjust how your underlying condition is managed. This is not a solo, middle-of-the-night decision. There is also a pregnancy exposure registry for semaglutide that collects outcome data, and your clinician can explain how to take part if you wish. Getting proper prenatal care underway is the priority.
Can I take Ozempic while breastfeeding?
The Ozempic label advises against use while breastfeeding, because it is not known whether semaglutide passes into human milk or how it might affect a nursing infant, and the human data is limited. If weight or blood-sugar management is a concern during this period, discuss nursing-compatible options with your clinician rather than restarting the drug on your own.
Sources
Related reading
The Complete GLP-1 Guide for Beginners
What GLP-1s are. How they work in the body. Who they are approved for. The four drugs on the market. Explained without the hype.
Mounjaro vs Ozempic vs Wegovy vs Zepbound
The four big GLP-1 drugs compared on mechanism, efficacy, side effects, and cost. What the trials actually showed, side by side.
12 Questions to Ask Before Starting a GLP-1
Prep for your first GLP-1 appointment: 12 questions worth asking, why each matters, and what a good answer looks like.
